Detection of occult malignant melanoma by18F-FDG PET-CT and gamma probe;Detection de melanoma maligno oculto mediante PET-TC con18F-FDG y sonda gammadetectora

Revista Espanola de Medicina Nuclear

Volumn 24, Issue 6, 2005, Pages 410-413

  Carrera, D ^a   Fernandez A ^a,b   Estrada, J ^a   Martin Comin J ^a   Gamez C ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Unitat PET IDI Centre Bellvitge   (Spain)

Author keywords

18F FDG; Gamma probe; Malignant melanoma; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MELANOMA; MESENCHYMOMA; OCCULT CANCER; SCINTISCANNING; TUMOR LOCALIZATION; TUMOR RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; HEMANGIOMA; INTERVENTIONAL RADIOLOGY; KNEE; LEIOMYOMA; LIVER TUMOR; METASTASIS; NEEDLE BIOPSY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SECOND CANCER; SKIN TUMOR; SOFT TISSUE TUMOR; THIGH; UTERUS CANCER;

ADULT; BIOPSY, FINE-NEEDLE; FEMALE; HEMANGIOMA; HUMANS; KNEE; LEIOMYOMA; LIVER NEOPLASMS; MELANOMA; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOLOGY, INTERVENTIONAL; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; THIGH; TOMOGRAPHY, X-RAY COMPUTED; UTERINE NEOPLASMS;

EID: 30944444978     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0212-6982(05)74186-0     Document Type: Article

References (9)

1. Damian DL, Fulham MJ, Thompson E, Thompson JF. Positron emission tomography in the detection and management of malignant melanoma. Melanoma Res. 1996;6:325-9.
2. Paquet P, Hustinx R, Rigo P, Pierard GE. Malignant melanoma staging using whole-body positron emission tomography. Melanoma Res. 1998;8:59-62.
3. Crippa F, Leutner M, Belli F, Gallino F, Greco M, Pilotti S, et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med. 2000;41:1491-4.
4. Rinne D, Baum RP, Hor G, Kaufmann R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer. 1998;82:1664-71.
5. Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, et al. A review of the literature for whole-body FDG PET in the management of patients with melanoma. QJ Nucl Med. 2000;44:153-67.
6. Abella-Columna E, Valk PE. Positron emission tomography imaging in melanoma and lymphoma. Semin Roentgenol. 2002;37:129-39.
7. Balch CM, Buzaid AC, Atkins MB. Revised American Joint Comittee on Cancer melanoma staging. Cancer. 2000;88:1484-991.
8. Essner R, Hsueh EC, Haig PI, Glass EC, Huynh Y, et al. Application of an F-18 fluorodeoxiglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res. 2001;97:120-6.
9. 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study. Annals of Nuc Med. 2004;18:105-14.